Ceftavit-TZ 1.125 Injection
Marketer
Vivaceutical
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Ceftavit-TZ 1.125 Injection
Ceftavit-TZ 1.125 Injection, a dual-action medication, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under a physician's guidance; strict adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects necessitate immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) require prompt emergency care. Prior to commencing treatment, inform your doctor of all current medications and pre-existing conditions. Expectant or nursing mothers should seek medical counsel. Alcohol consumption should be avoided due to potential synergistic drowsiness. While generally not impairing driving ability, refrain from operating vehicles if drowsiness or dizziness occurs. Adequate rest, nutritious food, and ample hydration are recommended for optimal recovery. Your physician may order laboratory and diagnostic tests to monitor treatment response.
Uses of Ceftavit-TZ 1.125 Injection
Infections caused by bacteria
Major Benefits of Ceftavit-TZ 1.125 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ceftavit-TZ 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceftavit-TZ 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ceftavit-TZ 1.125 Injection works:
Ceftriaxone and Tazobactum, combined as Ceftavit-TZ 1.125 Injection, offer a targeted antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to multiply. Tazobactum's role as a beta-lactamase inhibitor counteracts bacterial resistance mechanisms, thus improving Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Ceftavit-TZ 1.125 Injection and alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Ceftavit-TZ 1.125 is typically deemed safe for pregnant individuals. Preclinical trials using animal models have revealed minimal or no negative consequences for fetal development; nonetheless, clinical data from human studies are scarce.
Breast feedingCAUTION
The administration of Ceftavit-TZ 1.125 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the course of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
Ceftavit-TZ 1.125 Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Ceftavit-TZ 1.125 Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The use of Ceftavit-TZ 1.125 Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Ceftavit-TZ 1.125 Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ceftavit-TZ 1.125 Injection :
Omitting a scheduled Ceftavit-TZ 1.125 Injection necessitates contacting your physician.
Facts to Know About Ceftavit-TZ 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
3,018 People bought this recently